glutathione gbm6 patient derived xenograft Frontiers Metabolic difference between patient-derived xenograft
Metabolic difference between patient derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor BMC Cancer Springer Nature Link Patient derived tumour xenografts as models for oncology drug development Nature Reviews Clinical Oncology Patient derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas Cancer Cell International Springer Nature Link Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ScienceDirect
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




